Cyclooxygenase inhibitory natural products: current status

Area of Science:

• Pharmacology
• Natural Products Chemistry
• Medicinal Chemistry

Background:

• Non-steroidal anti-inflammatory drugs (NSAIDs) target cyclooxygenase (COX) enzymes.
• Selective COX-2 inhibitors offer anti-inflammatory benefits with fewer gastrointestinal issues than non-selective NSAIDs.
• Concerns regarding cardiovascular events associated with some selective COX-2 inhibitors, like rofecoxib, highlight the need for safer alternatives.

Purpose of the Study:

• To review natural product-based cyclooxygenase (COX) inhibitors from plant and marine sources reported in the last decade.
• To evaluate the advantages, potential for further development, and current status of these natural COX inhibitors.
• To present insights into the characterization, design, and synthesis of potential natural COX inhibitors.

Main Methods:

• Literature review of natural product COX inhibitors from the past 10 years.
• Analysis of reported advantages and potential for drug development.
• Discussion of semi-synthetic modifications to enhance COX-2 selectivity.

Main Results:

• Natural product-based compounds are generally COX-1 selective but can be modified for COX-2 selectivity.
• Plant and marine sources yield compounds with potential anti-inflammatory properties.
• The COX-2/COX-1 selectivity ratio is crucial for drug design, aiming to minimize side effects.

Conclusions:

• Natural product-derived COX inhibitors present a promising avenue for developing safer anti-inflammatory drugs.
• Further research into semi-synthetic modifications can optimize the therapeutic profile of natural COX inhibitors.
• These compounds offer potential advantages over synthetic NSAIDs, particularly regarding gastrointestinal and cardiovascular safety.